PathTezt is an advanced cervical cytology test that aids in the early detection of abnormalities, precancerous lesions, or early-stage cervical cancer before symptoms appear. Gynecologists use specialized instruments and reagents to collect cervical cells from the patient and send to the laboratory. In the laboratory, pathologists analyze these cells under a light microscope to determine the presence or absence of: (1) Infectious agents (such as Candida spp., Actinomyces, HSV, HPV, etc.); (2) Precancerous cells; (3) Cancerous cells. Pap smear is a modern and painless test that contributes to improve treatment success rates and reduces the incidence and mortality of cervical cancer in women.
Compared to traditional Pap smears, PathTezt offers several advantages:
- Fully automated sample processing.
- 100% cell collection and preservation in a liquid-based medium, maintaining the original cell morphology and preventing cell damage or dehydration.
- Blood and mucus lysis, enabling clear cell visualization, easier reading, and high representation.
- Capability to perform additional tests, such as STD or HPV testing, without requiring extra samples.